Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042 by Mansfield, Aaron S., MD, Herbst, Roy S., MD, PhD, de Castro, Gilberto, MD, PhD, Hui, Rina, MB, BS, PhD, Peled, Nir, MD, PhD, Kim, Dong-Wan, MD, Novello, Silvia, MD, PhD, Satouchi, Miyako, MD, Wu, Yi-Long, MD, Garon, Edward B., MD, Reck, Martin, MD, PhD, Robinson, Andrew G., MD, Samkari, Ayman, MD, Piperdi, Bilal, MD, Ebiana, Victoria, MD, Lin, Jianxin, MS, Mok, Tony S.K., MD

Get full text